Vertex Pharmaceuticals | VRTX - Capitalisation Boursière

Prix De L'Action
430.29
Variation Quotidienne
-4.81 -1.11%
Mensuellement
-5.42%
Annuel
-12.87%
Q2 Prévisions
421.08




Capitalisation Boursière Changement Date
AbbVie USD 403.83B 5.2B 2025-12
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amgen USD 176.25B 24.32B 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
Incyte USD 19.39B 2.83B 2025-12
Insmed USD 37.12B 6.68B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
J&J USD 561.65B 17.5B 2026-04
Merck USD 261.26B 51.62B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 292.21B 26.55B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
PTC Therapeutics USD 5.26B 844M 2026-04
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 101.43B 1.16B 2026-04
Sarepta Therapeutics USD 2.26B 238M 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12